Wednesday, January 16, 2019 12:03:58 PM
One giant pharma stock that I have been following lately is Johnson and Johnson (NYSE:JNJ). Last month, the stock plunged lower after news was reported that the company could still have issues regarding its popular baby powder product. On December 13, 2018, the shares traded as high as $148.58 a share. On December 24, 2018 the shares traded as low as $121.00 before finding a near term bottom with the major stock market indexes. Today, JNJ stock is trading at $128.42 a share. So while the shares have certainly bounced higher they have not come close to their December 13th high. In fact, the stock is signaling weak relative strength at this time. Traders should note that the stock is still trading below its important 200-day moving average, this is actually a sign of weakness. Should the stock break below the key $121.00 support level it would trigger another sell signal in the stock. The next major support level for JNJ stock would be around the $113.00 area. Right now, JNJ is hanging in there, but this is a stock that I will be watching closely.
Nick Santiago
InTheMoneyStocks
Recent JNJ News
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
